Predictive factors of peak radioactive iodine uptake moving forward in Graves' disease patients receiving iodine-131 therapy

被引：0
|
作者：
Zhang, R. [1 ]
Qin, L. [1 ]
Wang, J. [1 ]
机构：
[1] Tianjin First Cent Hosp, Dept Nucl Med, Tianjin, Peoples R China
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P613
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [41] Association between radioactive iodine uptake and neutropenia in untreated Graves' disease
    Yang, Qian
    Ke, Wencai
    Pan, Fanfan
    Huang, Xinmei
    Liu, Jun
    Zha, Bingbing
    ENDOCRINE CONNECTIONS, 2023, 12 (02)
  • [42] The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease
    Hancock, LD
    Tuttle, RM
    LeMar, H
    Bauman, J
    Patience, T
    CLINICAL ENDOCRINOLOGY, 1997, 47 (04) : 425 - 430
  • [43] Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves? Disease
    Kim, Min Joo
    Cho, Sun Wook
    Kim, Ye An
    Choi, Hoon Sung
    Park, Young Joo
    Park, Do Joon
    Cho, Bo Youn
    ENDOCRINOLOGY AND METABOLISM, 2022, 37 (03) : 524 - 532
  • [44] The clinical analysis of 50 pregnant women with a history of iodine-131 treatment for Graves' disease
    Guan, Liang
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [45] Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves' disease in different periods
    Zhao, Aomei
    Zhang, Jing
    Xue, Jianjun
    Lu, Xueni
    Wang, Qi
    Ji, Ting
    Yang, Lulu
    Yu, Yan
    Yang, Aimin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] Recurrence-free survival and prognostic factors after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Iizuka, Y.
    Katagiri, T.
    Ogura, K.
    Inoue, M.
    Nakamura, K.
    Mizowaki, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S364 - S364
  • [47] Is low radioactive iodine uptake really an adverse factor in the outcome of radioiodine therapy of Graves disease?
    Damle, Nishikant
    Reddy, Ramamohan
    Bal, C.
    Kumar, Praveen
    Maharjan, Sagar
    Gupta, Priyanka
    Kumar, Rajender
    Sharma, Punit
    Malhotra, Arun
    Jeph, Sunil
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [48] Evaluation of osseous tissue response to minor oral surgical procedures in the first 9 months after radioactive iodine-131 therapy in adult female patients with Graves Disease
    Abd El-Ghany, A. M. A. A.
    Mohamed, M. N. F. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S169 - S169
  • [49] Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
    Lakhdar, Majdouline Bel
    Mouaden, Ayat
    Zekri, Mourad
    Alami, Dounia
    Zarouf, Hamza
    Ghfir, Imad
    Guerrouj, Hasnae
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2024, 23 (03) : 185 - 190
  • [50] Management of hyperthyroid patients following radioactive iodine therapy, with a specific emphasis on Graves' disease
    Taieb, D.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (04): : 284 - 286
12345